NKTR Competitors & Alternatives
Compare Nektar Therapeutics with similar stocks in the same industry
Biotechnology
NKTR
Main Stock$43.58
Tradestie Score
44
Market Cap
$1.12B
Revenue Growth
-0.1%
Analyst Upside
+224.5%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLDX
Celldex Therapeutics, Inc
|
$31.65
|
$1.68B | - | 60 | Compare |
|
MNKD
Mannkind Corporation
|
$3.80
|
$1.65B | - | 50 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$41.40
|
$1.63B | - | 46 | Compare |
|
BHVN
Biohaven Ltd.
|
$12.87
|
$1.57B | - | 50 | Compare |
|
VCEL
Vericel Corporation
|
$40.15
|
$1.56B | 83.9 | 57 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$88.21
|
$1.55B | - | 63 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$39.64
|
$1.55B | 12.7 | 60 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$31.19
|
$1.55B | - | 54 | Compare |
|
NVAX
Novavax Inc
|
$10.46
|
$1.54B | - | 41 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$15.83
|
$1.50B | 7.0 | 49 | Compare |
More NKTR Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry